Venture-backed Xagenic picks Timothy Still as new president and CEO
Xagenic Inc has named Timothy I. Still as its new president and CEO. He will also serve on the company's board of directors. Still previously led Accumetrics Inc, a U.S.-based point-of-care test manufacturer acquired by ITC Nexus Holding Co in 2013. Based in Toronto, Xagenic is the developer of a fully-automated molecular diagnostic platform that will enable lab-free testing. It is backed by a number of Canadian and U.S. venture capital firms, including BDC Capital, CTI Life Sciences Fund, Domain Associates and Ontario Capital Growth Corp.
16 October 2014•3 mins read
